LONDON and MINNEAPOLIS, Sept. 19, 2023 /PRNewswire/ Bio-Techne Corporation and Cizzle Biotechnology Holdings plc, the UK-based diagnostics developer, are pleased to announce recent progress.
/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor healthcare conferences: 2023 Wells Fargo.
/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at.
/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, August 8, 2023, at.